Provided by Tiger Fintech (Singapore) Pte. Ltd.

Core Assets of Southward Funds

1,095.711
+22.5652.10%
Number of Gainers:52
Number of Losers:14
Number of Flat:1
PE:- -
High:1,097.571
Open:1,073.146
Low:1,073.146
Close:1,073.146
Loading ...

China Mobile Completes Purchase of 15% Stake in Broadband Operator

MT Newswires Live
·
07 May

Geely Automobile Submits Bid to Take EV Brand Zeekr Private

MT Newswires Live
·
07 May

Country Garden Services to Provide 1 Billion Yuan Loan Facilities

MT Newswires Live
·
07 May

BUZZ-Chinese EV maker Zeekr gains on privatisation offer from Geely Auto

Reuters
·
07 May

Zeekr Shares Jump 10.7% Premarket After Geely Automobile to Take Co Private

THOMSON REUTERS
·
07 May

BRIEF-Geely's Chairman: Move To Take Zeekr Private Is In Line With Goal To Return To "One Geely" - Company Statement

Reuters
·
07 May

Geely: Zeekr Will Be Fully Merged Into Geely Auto IF the Privatisation Completes - Company Statement

THOMSON REUTERS
·
07 May

Geely's Chairman: Promoting Integration of Auto Business in the Face of Fierce Market Competition and Increasingly Complex Economic Environment - Comapny Statement

THOMSON REUTERS
·
07 May

Geely's Chairman: Move to Take Zeekr Private Is in Line With Goal to Return to "One Geely" - Company Statement

THOMSON REUTERS
·
07 May

Geely's Chairman: Will Continue to Maintain Close Communication and Cooperation With the US and International Capital Markets - Company Statement

THOMSON REUTERS
·
07 May

BRIEF-Geely Automobile Announces Non-Binding Proposal On Proposed Privatisation Of Zeekr

Reuters
·
07 May

HK-Listed Geely Eyes Privatisation Of Chinese Unit ZEEKR

Reuters
·
07 May

Geely Automobile - Non-Binding Proposal in Relation to Proposed Privatisation of Zeekr by Group

THOMSON REUTERS
·
07 May

Geely Automobile - Company Proposed to Value Zeekr at US$2.566 per Zeekr Share or US$25.66 per Ads

THOMSON REUTERS
·
07 May

Innovent Biologics Launches Phase 2 Clinical Study of Efdamrofusp Alfa for Diabetic Macular Edema Treatment

Reuters
·
07 May

Bispecific VS. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (Ibi302), a First-in-Class Anti-Vegf and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema

THOMSON REUTERS
·
07 May

BRIEF-Country Garden Services To Provide Loan Facilities In Aggregate Principal Amount Of RMB1 Billion

Reuters
·
07 May

Country Garden Services - Co to Provide Revolving Loan Facilities in an Aggregate Principal Amount of RMB1 Bln

THOMSON REUTERS
·
07 May

Auto file: Fog of (trade) war

Reuters
·
06 May

Hong Kong launches new measures to attract more tech, bio listings

Reuters
·
06 May